N.-X. Peng, C.-X. Liu, X.-S. Wang, Z.-J. Zhang, and S.-C. Liao, “Combination of axitinib and dasatinib for anti-cancer activities in two prostate cancer cell lines”, Bangladesh J Pharmacol, vol. 11, no. 1, pp. 130–137, Dec. 2015.